Overview

Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia

Status:
Completed
Trial end date:
2018-03-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the clinical efficacy and the safety of P-3074 in participants with androgenetic alopecia.
Phase:
Phase 3
Details
Lead Sponsor:
Polichem S.A.
Treatments:
Finasteride
Pharmaceutical Solutions